Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
Lateef
F
F
Don
P C
PC
Kaufmann
M
M
White
S M
SM
Weinberg
J M
JM
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000212:Acyclovir / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005148:Facial Dermatoses / Q000150:complications / Q000188:drug therapy* / Q000821:virology*; D017245:Foscarnet / Q000627:therapeutic use; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D017211:Treatment Failure
D019380:Anti-HIV Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D000212:Acyclovir